Skip to main content
. 2021 May 3;2021:9678363. doi: 10.1155/2021/9678363

Table 3.

The analysis of prognosis factors in 336 gastric cancer patients with MGC component by univariate and multivariate.

Variables Univariate analysis Multivariate analysis
5-YSR (%) P value HR (95% CI) P value
Sex Male 42.2 0.161
Female 51.5
Age (years) <59 54.4 0.001 1.876 (1.361-2.585) <0.001
≥59 36.4
R0/R1&2 resection R0 51.1 <0.001 1.384 (0.927-2.067) 0.112
R1/R2 14.3
Tumor size (cm) <5.25 59.9 <0.001 0.884 (0.608-1.286) 0.520
≥5.25 32.6
pMGC/mMGC mMGC 47.4 0.211
pMGC 39.8
Chemotherapy Yes 47.1 0.191
No 43.1
T-stage T1 88.9 <0.001 1.289 (0.948-1.753) 0.106
T2 78.4
T3 48.8
T4 35.7
N-stage N0 80.6 <0.001 1.136 (0.962-1.341) 0.132
N1 49.2
N2 40.3
N3a 29.5
N3b 17.4
TNM I+II 78.4 <0.001 2.350 (1.216-4.542) 0.011
III 30.3
Tumor location L 54.4 <0.001 1.103 (0.982-1.238) 0.097
M 38.3
U 28.6
LM 34.2
MU 18.2
LMU 20.0
Leukocyte <6.17 49.2 0.077
≥6.17 39.7
Neutrophil <3.31 50.6 0.030 1.174 (0.818-1.684) 0.384
≥3.31 40.1
Hemoglobin <125.1 36.9 0.009 1.096 (0.785-1.528) 0.591
≥125.1 51.3
Fibrinogen <3.31 52.6 0.005 0.897 (0.655-1.230) 0.500
≥3.31 36.8
Albumin <40.1 35.1 <0.001 0.761 (0.553-1.046) 0.092
≥40.1 53.0
Globulin <29.2 48.0 0.039 1.520 (1.067-2.165) 0.020
≥29.2 35.4
NLR <1.6 55.8 0.002 1.012 (0.662-1.548) 0.956
≥1.6 39.5
Platelet <243 51.8 0.010 0.895 (0.619-1.293) 0.554
≥243 38.0
PLR <133 55.6 <0.001 1.582 (1.066-2.348) 0.023
≥133 34.5
Total gastrectomy Yes 21.7 <0.001 0.537 (0.373-0.772) 0.001
No 53.7

P < 0.05; 5-YSR = 5-year survival rate; L = lower; M = middle; U = upper; NLR = neutrophil-to-lymphocyte ratio; PLR = platelet-to-lymphocyte ratio; MGC = mucinous gastric carcinoma.